1.
Strober B, Papp KA, Flack M, Gu Y, Thompson EH, Valdecantos WC. Distribution of Improvements in Psoriasis Area and Severity Index from the Phase 2 Trial of Risankizumab in Moderate-to-Severe Plaque Psoriasis. J of Skin [Internet]. 2017Oct.27 [cited 2022Jul.1];1(3.1):s10. Available from: https://www.jofskin.org/index.php/skin/article/view/78